Sr. Director/Executive Director, Global Value, Access & Pricing Lead Hematology @ BeiGene | Jobright.ai
JOBSarrow
RecommendedLiked
0
Applied
0
External
0
Sr. Director/Executive Director, Global Value, Access & Pricing Lead Hematology jobs in Remote (US)
27 applicants
company-logo

BeiGene · 3 hours ago

Sr. Director/Executive Director, Global Value, Access & Pricing Lead Hematology

ftfMaximize your interview chances
BiotechnologyHealth Care
check
H1B Sponsor Likelynote

Insider Connection @BeiGene

Discover valuable connections within the company who might provide insights and potential referrals.
Get 3x more responses when you reach out via email instead of LinkedIn.

Responsibilities

Lead the development and execution of global access and value strategies for BeiGene’s hematology assets, ensuring alignment with commercial and corporate goals.
Collaborate closely with GPTs, Clinical, HEOR, Medical Affairs, and Commercial teams to define product value propositions based on clinical data, economic models, and patient outcomes.
Develop and maintain robust value toolkits—including tight collaboration with HEOR on health economic models, value dossiers, and clinical data summaries—to support global and regional teams in local access and pricing discussions.
Define together with the Global Head of Strategic & Operational Pricing strategies and governance processes for both in-market and pipeline hematology products, adapting to evolving market access requirements.
Analyze market trends, payer requirements, and competitive dynamics to optimize pricing and reimbursement approaches across key global markets.
Partner with regional and affiliate pricing teams of Focus markets to support effective implementation of global pricing strategies, ensuring alignment with local market access and regulatory requirements.
Oversee market access planning and value demonstration for BeiGene’s hematology pipeline (incl. potential in-license assets) products to ensure readiness for new product launches.
Develop pre-launch value strategies and support local launch teams with comprehensive value toolkits and market-specific materials for payer and provider engagement.
Collaborate with Global Medical Affairs and GPTs to ensure market access requirements are integrated into clinical trials and evidence-generation strategies.
Act as the primary point of contact for market access, value, and pricing matters related to the hematology portfolio, fostering alignment across Global, Regional, and Local teams.
Identify payer archetypes and associated needs, in close collaboration with the regional market access leads, to optimize pricing and reimbursement regionally and locally, with consistency globally, as required.
Engage and communicate with key internal stakeholders, including R&D, Medical Affairs, Regulatory, and Commercial teams, to build alignment on access and pricing strategies.
Present and advocate for access and pricing strategies at senior leadership and executive meetings, communicating value strategies and anticipated market access outcomes.
Expand knowledge and experience by regular engagement with key stakeholders to understand business processes, policies, strategies, and evolving business trends.
Represent Market Access in the respective GPTs and GBT
Lead, mentor, and inspire a team of individual contributors, fostering a high-performance culture focused on achieving global market access objectives.
Provide strategic guidance, coaching, and development opportunities to build capabilities in market access, health economics, and pricing within the team.
Ensure the team stays up-to-date with market trends, payer policies, and regulatory changes that impact hematology access, value, and pricing strategies.
Continuously monitor the global hematology landscape, including competitive products, new therapies, payer requirements, and regulatory policies impacting access and pricing.
Utilize insights from global markets to refine and optimize value messages, toolkits, and access strategies to anticipate and respond to payer and market needs.
Ensures compliance with all Company policies and procedures, including safety rules and regulations.
Ensure P&R insights are embedded in product plans throughout the lifecycle.
Manage the global P&R budget for the therapeutic area, ensure that the resources are optimized and focused on critical activities to achieve revenue, profit, and market access share objectives.

Qualification

Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.

Market Access StrategiesHealth EconomicsPricing StrategiesValue Proposition DevelopmentClinical Data AnalysisRegulatory RequirementsMarket InsightsCross-Functional CollaborationEmbraces ChangeFinancial ExcellenceSelf-AwarenessCollaborative Spirit

Required

Master’s degree required, preferably in science or Health Economics.
Experience in developing and executing access, value, and pricing strategies for hematology products.
Ability to collaborate closely with various teams including GPTs, Clinical, HEOR, Medical Affairs, and Commercial teams.
Experience in developing value toolkits and health economic models.
Strong analytical skills to analyze market trends, payer requirements, and competitive dynamics.
Experience in overseeing market access planning and value demonstration for pipeline products.
Ability to engage and communicate with key internal stakeholders.
Experience in leading and mentoring a team of individual contributors.
Knowledge of global hematology landscape, including competitive products and payer requirements.
Ability to manage the global P&R budget for the therapeutic area.

Preferred

PhD preferred.

Company

BeiGene is a global oncology company.

H1B Sponsorship

BeiGene has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (28)
2022 (36)
2021 (34)
2020 (22)

Funding

Current Stage
Public Company
Total Funding
$6.79B
Key Investors
Hillhouse InvestmentAmgen
2020-07-12Post Ipo Equity· $2.08B
2019-10-31Post Ipo Equity· $2.7B
2018-08-02Post Ipo Secondary· $903M

Leadership Team

leader-logo
John V. Oyler
CEO & Founder
linkedin
leader-logo
Aaron Rosenberg
Chief Financial Officer
linkedin
Company data provided by crunchbase
logo

Orion

Your AI Copilot